Clinical trial Recruiting at 1 site Interventional Ages 18 to 40

Guided lateral sinus lift using autologous serum albumin with platelet-rich fibrin (Alb-PRF)

Official title: Computer-Guided Lateral Sinus Floor Elevation Using Autologous Serum Albumin/Platelet Rich Fibrin Combined With Serum Albumin Membrane: A Randomized Clinical Study

Run by Kafrelsheikh University · NCT07348094 · Data updated 2026-11-12

This trial will test whether using your own serum albumin combined with platelet-rich fibrin (Alb-PRF) during a guided lateral sinus lift helps bone regrow for adults needing implants in the back upper jaw.

More Dental Implant trials

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexAll
Enrollment45 (estimated)
SponsorKafrelsheikh University
Academic / other
Locations1 site (Kafr ash Shaykh, Kafrelsheikh)
StatusRecruiting
StartedJanuary 26, 2026
Main results expectedJanuary 30, 2027
Study endsFebruary 15, 2027
Registry record updatedFebruary 18, 2026
Trial IDNCT07348094 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) in good general health (ASA I–II) with partial edentulism in the posterior maxilla, native non-augmented bone, horizontal ridge ≥5 mm, vertical ridge 3–6 mm, D2–D3 bone quality, and adequate inter-arch distance are ideal candidates.

Probably not a fit

Patients with uncontrolled systemic disease, chronic maxillary sinus pathology, heavy smoking, poor oral hygiene, or insufficient ridge dimensions are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants with partial tooth loss in the posterior maxilla will undergo guided lateral sinus augmentation using stereolithographic guides and digital planning. They will receive one of three approaches: conventional bone graft, Alb-PRF derived from their own blood, or sticky bone, and bone gain will be measured with 3D volumetric CBCT analysis. The protocol emphasizes precise lateral window placement to reduce membrane perforation and to allow simultaneous implant placement when appropriate. Standard inclusion criteria include adults with limited vertical ridge height and adequate horizontal ridge width, while patients with uncontrolled systemic disease or chronic sinus pathology are excluded.

Why it matters

Potential benefit: If successful, using Alb-PRF could reduce or replace the need for foreign bone graft material and enhance bone formation using the patient's own blood products, potentially simplifying sinus lift procedures and improving implant success.

How similar studies have gone: Previous clinical reports of PRF and Alb-PRF in sinus augmentation and guided bone regeneration have shown promising bone-healing and reduced complications, but fully replacing conventional bone grafts is not yet firmly established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Males and females ≥18 years of age.

  * ASA I and ASA II.
  * Patients having partial edentulism in the posterior region of the maxilla.
  * Edentulous sites consist of native non augmented bone.
  * Horizontal ridge dimension minimum of 5mm
  * The vertical ridge dimension 3-6 mm.
  * Bone quality of D2 or D3.
  * Enough inter-arch distance.

Exclusion Criteria:

* \- Patients with uncontrolled systemic diseases.
* History of chronic maxillary sinus pathology.
* Heavy smokers or patients with poor oral hygiene.

Where it's running

  • faculty of dentistry, kafrelsheikh University
    Kafr ash Shaykh, Kafrelsheikh, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.